{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:23:06Z","timestamp":1788045786636,"version":"build-2784847793"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/aci.0b013e328364ec3a","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T05:38:02Z","timestamp":1377236282000},"page":"543-549","source":"Crossref","is-referenced-by-count":56,"title":["Allergic conjunctivitis"],"prefix":"10.1097","volume":"13","author":[{"given":"Terrence P.","family":"O\u2019Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210128","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: update on pathophysiology and prospects for future treatment.","volume":"115","author":"Ono","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"R2-15-20210128","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/ACI.0b013e32834a9676","article-title":"Epidemiology of allergic conjunctivitis.","volume":"11","author":"Rosario","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"Suppl 86","key":"R3-15-20210128","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"R4-15-20210128","first-page":"149","article-title":"Updates in the treatment of ocular allergies.","volume":"3","author":"Kari","year":"2010","journal-title":"J Asthma Allergy"},{"key":"R5-15-20210128","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1067\/mai.2000.111238","article-title":"Allergic and immunologic disorders of the eye. Part II: ocular allergy.","volume":"106","author":"Bielory","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"R6-15-20210128","first-page":"485","article-title":"Ocular allergy: diagnosis and treatment.","volume":"18","author":"Butrus","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"R9-15-20210128","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/1097-0142(19840601)53:11<2515::AID-CNCR2820531125>3.0.CO;2-C","article-title":"Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue.","volume":"53","author":"Isaacson","year":"1984","journal-title":"Cancer"},{"key":"R10-15-20210128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.iac.2007.12.005","article-title":"Allergic conjunctivitis.","volume":"28","author":"Bielory","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"R11-15-20210128","first-page":"16","article-title":"Classifying and managing allergic conjunctivitis.","volume":"8","author":"Moloney","year":"2007","journal-title":"Med Today"},{"key":"R12-15-20210128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1477-7525-3-67","article-title":"The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).","volume":"3","author":"Alexander","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"R13-15-20210128","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","article-title":"Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup.","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"key":"R14-15-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.iac.2007.12.011","article-title":"Ocular allergy overview.","volume":"28","author":"Bielory","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"R15-15-20210128","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","article-title":"Dysfunctional tear syndrome: a Delphi approach to treatment recommendations.","volume":"25","author":"Behrens","year":"2006","journal-title":"Cornea"},{"key":"R16-15-20210128","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archopht.1990.01070030090035","article-title":"Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis.","volume":"108","author":"Abelson","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"R17-15-20210128","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1398-9995.1984.tb01931.x","article-title":"The precision of the conjunctival provocation test.","volume":"39","author":"Moller","year":"1984","journal-title":"Allergy"},{"key":"R18-15-20210128","doi-asserted-by":"crossref","first-page":"S718","DOI":"10.1016\/j.jaci.2011.12.274","article-title":"Comparison of environmental and allergen-challenge based assessments of allergic conjunctivitis treatment using an antihistamine-steroid combination therapy.","volume":"129","author":"Gomes","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R19-15-20210128","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1755-3768.2011.02272.x","article-title":"Management of seasonal allergic conjunctivitis: guide to therapy.","volume":"90","author":"Bielory","year":"2012","journal-title":"Acta Ophthalmol"},{"key":"R20-15-20210128","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2011.09.005","article-title":"Histamine and H1-antihistamines: celebrating a century of progress.","volume":"128","author":"Simons","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R21-15-20210128","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter.","volume":"122","author":"Wallace","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"R22-15-20210128","first-page":"87","article-title":"Evaluation of alcaftadine 0.25 ophthalmic solution in acute allergic conjunctivitis at 15 min and 16h after instillation versus placebo and olopatadine 0.1.","volume":"5","author":"Greiner","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"R23-15-20210128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1185\/03007995.2010.548797","article-title":"The safety and efficacy of alcaftadine 0.25 ophthalmic solution for the prevention of itching associated with allergic conjunctivitis.","volume":"27","author":"Torkildsen","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"R24-15-20210128","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2147\/OPTH.S13479","article-title":"Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis.","volume":"4","author":"Williams","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"R25-15-20210128","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1398-9995.1998.tb03991.x","article-title":"Azelastine eye-drops in seasonal allergic conjunctivitis or rhinoconjunctivitis: a double-blind, randomized, placebo-controlled study.","volume":"53","author":"Giede-Tuch","year":"1998","journal-title":"Allergy"},{"key":"R26-15-20210128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1185\/030079903125001794","article-title":"Topical azelastine in perennial allergic conjunctivitis.","volume":"19","author":"Canonica","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"R27-15-20210128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2500\/aap.2013.34.3671","article-title":"Efficacy of bepotastine besilate ophthalmic solution 1.5 for seasonal allergic conjunctivitis: a randomized, placebo-controlled, natural exposure, clinical trial.","volume":"34","author":"Carr","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"R28-15-20210128","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2500\/aap.2012.33.3570","article-title":"Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5 for ocular itching associated with allergic conjunctivitis.","volume":"33","author":"Meier","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"R29-15-20210128","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2147\/OPTH.S35431","article-title":"Comparative efficacy of bepotastine besilate 1.5 ophthalmic solution versus olopatadine hydrochloride 0.2 ophthalmic solution evaluated by patient preference.","volume":"6","author":"McCabe","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"R30-15-20210128","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.clinthera.2009.09.001","article-title":"Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0 and 1.5 in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.","volume":"31","author":"Abelson","year":"2009","journal-title":"Clin Ther"},{"key":"R31-15-20210128","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajo.2010.02.007","article-title":"Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0 and 1.5 to treat allergic conjunctivitis.","volume":"150","author":"Macejko","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R32-15-20210128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0149-2918(04)90003-3","article-title":"Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis.","volume":"26","author":"Whitcup","year":"2004","journal-title":"Clin Ther"},{"key":"R33-15-20210128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.iio.0000212128.45395.a5","article-title":"Epinastine in the management of ocular allergic disease.","volume":"46","author":"Friedlaender","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"R34-15-20210128","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0002-9394(98)00044-0","article-title":"Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity.","volume":"125","author":"Abelson","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R35-15-20210128","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1034\/j.1600-0420.2000.078s230060.x","article-title":"An evaluation of onset and duration of action of patanol (olopatadine hydrochloride ophthalmic solution 0.1) compared to Claritin (loratadine 10mg) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge model.","volume":"78","author":"Abelson","year":"2000","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"R36-15-20210128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1081-1206(10)62814-1","article-title":"Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model.","volume":"81","author":"Abelson","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R37-15-20210128","first-page":"35","article-title":"Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.","volume":"9","author":"Bielory","year":"2007","journal-title":"MedGenMed"},{"key":"R38-15-20210128","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0149-2918(03)80069-3","article-title":"A combined analysis of two studies assessing the ocular comfort of antiallergy ophthalmic agents.","volume":"25","author":"Shulman","year":"2003","journal-title":"Clin Ther"},{"key":"R39-15-20210128","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00061198-199808000-00009","article-title":"Change in intraocular pressure during long-term use of loteprednol etabonate.","volume":"7","author":"Novack","year":"1998","journal-title":"J Glaucoma"},{"key":"R40-15-20210128","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-0420.2006.00699.x","article-title":"Effect of 0.03 tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study.","volume":"84","author":"Virtanen","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"R41-15-20210128","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/ICO.0b013e31812dfab3","article-title":"Management of severe allergic conjunctivitis with topical cyclosporin a 0.05 eyedrops.","volume":"26","author":"Ozcan","year":"2007","journal-title":"Cornea"},{"key":"R43-15-20210128","first-page":"477","article-title":"Immune mechanisms in allergic eye diseases: what is new Curr Opin Allergy Clin I","volume":"9","author":"Offiah","year":"2009","journal-title":"mmunol"},{"key":"R44-15-20210128","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/ACI.0b013e3283466fcb","article-title":"Determinants of patient compliance in allergic rhinoconjunctivitis.","volume":"11","author":"Koberlein","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R45-15-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00061198-200310000-00001","article-title":"Compliance barriers in glaucoma: a systematic classification.","volume":"12","author":"Tsai","year":"2003","journal-title":"J Glaucoma"},{"key":"R46-15-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1076\/opep.11.1.17.26437","article-title":"Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire.","volume":"11","author":"Pitt","year":"2004","journal-title":"Ophthalmic Epidemiol"}],"container-title":["Current Opinion in Allergy &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ACI.0b013e328364ec3a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:25:58Z","timestamp":1786047958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130832-201310000-00015"}},"subtitle":["an update on diagnosis and management"],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e328364ec3a","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}